The Centers for Medicare and Medicaid Services announced Thursday it plans to launch a study of "off-label" uses of anemia drugs, including those developed by Thousand Oak-based Amgen Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 26 biweekly issues
  • Subscriber-only digital content for prime stories
  • Book of Lists — the most comprehensive business resource in the Valley region
Yours for only $49